Khanh Nguyen Duy

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (3)

• Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
  The Lancet Regional Health - Western Pacific 2022 DOI: 10.1016/j.lanwpc.2022.100474
  +Save
• The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial
  Medrxiv 2022 DOI: 10.1101/2022.03.22.22272739
  +Save
• Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19
  Frontiers in Immunology 2021 DOI: 10.3389/fimmu.2021.766112
  +Save